JULY 2022LIFE SCIENCES REVIEW6The rising demand for personalized medicine, increasing support from local governments via initiatives and public policies, and faltering costs of sequencing services are driving Asia-Pacific's genomics market to record heights. This growth is also coupled with increasing partnerships among the key players in the market, who are aiming to expand their product portfolios, fostering their development and enhancing their global footprint. Governments in APAC are investing heavily in the implementation of several initiatives that promote the efficient development of genomics solutions. These solutions find application in a myriad of segments, such as diagnostics, precision medicine, drug development and delivery, animal research, and agriculture. According to P&S Intelligence, the market will witness a stagging 12.7% CAGR between 2022 and 2030. In 2019 alone, APAC's genomics market generated over 18 billion USD in revenue, which is expected to skyrocket to 68 billion by 2030. Owing to such significant growth and escalating utilization of high-throughput technologies, it is evident that APAC will continue to remain at the forefront of innovation in the global genomics firmament, enabling the life sciences community to enhance its offerings.This edition of Life Sciences Review APAC lays the spotlight on the key developments in APAC's genomics domain and how companies are leveraging contemporary technologies to mitigate the risks associated with mercurial market scenarios.This edition also features thought leadership articles by Narayana Rao, Vice President of Biopharma APAC-MEA and Marianthi Psaha, Global Head of Cell and & Gene Therapy of Santen, sharing their views on how cell and gene therapy will lead the biomanufacturing industry and how leveraging contemporary technologies can improve gene therapy.Along with that, the edition features innovative genomics solutions companies, including Genolution, OPTOLANE Technologies, and Zinexts. These companies offer groundbreaking genomics solutions, helping APAC's life science industry navigate the myriad of challenges associated with molecular biology, clinical research, drug development, and disease diagnostics.We present to you the "Top 10 Genomics Solution Providers in APAC - 2022."We hope the valuable insights from industry thought leaders and the cutting-edge solutions from the features companies in this edition help you make informed decisions. Let us know your thoughts / write to us about how you are leveraging these genomics solutions in your organizations to optimize your operations. EDITORIALUtilization of High-throughput Technologies Driving the Growth of GenomicsCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com JULY - 08 - 2022, Vol 03, Issue - 06 Published by ValleyMedia, Inc. (ISSN 2831-8331)To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersGiftson JoshuaJoe Philip Shirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >